You Position: Home > Paper
Expression of PKCβ1 and PKCβ2 in early gastric carcinoma
( views:201, downloads:14 )
- Author:
- No author available
- Journal Title:
- WORLD CHINESE JOURNAL OF DIGESTOLOGY
- Issue:
- 9
- DOI:
- 10.3969/j.issn.1009-3079.2003.09.006
- Key Word:
- No keyword available
Abstract： 目的:观察PKCβ1和PKCβ2在早期胃癌癌组织及其癌周不典型增生和肠上皮化生中的表达.方法:对42例早期胃癌胃全切标本的癌组织、癌旁不典型增生、肠上皮化生及正常胃黏膜进行PKCβ1和PKCβ2免疫组织化学染色.结果:正常胃黏膜上皮颈部散在PKCβ1阳性细胞,黏膜表面上皮细胞及幽门腺PKCβ1和PKCβ2阴性;胃底腺壁细胞和主细胞PKCβ1和PKCβ2呈强阳性.胃黏膜内淋巴滤泡中心区PKCβ1强阳性,PKCβ2阴性;相反,淋巴滤泡帽带区PKCβ1阴性,而PKCβ2强阳性.胃癌、癌旁不典型增生、肠上皮化生PKCβ1的表达明显增强,而PKCβ2的表达无明显增强,肠型胃癌PKCβ1的表达明显高于弥漫型.PKC β1的表达与早期胃癌的浸润深度无关.结论:PKC β1在胃黏膜腺上皮颈部和淋巴滤泡中心的强阳性表达提示PKC β1可能与细胞的增生活性有关;胃癌及癌前病变中PKC β1的表达增强显示PKC β1参与了胃癌的癌变过程,并可能在癌变早期发生改变.
- [1]韩英,时永全,张宏博,等.肿胀激活状态下蛋白激酶C同工酶亚型在胃癌耐药细胞系的亚细胞分布变化[J].2001,(6).
- [2]马强,张振书,张亚历,等.蛋白激酶C对大肠癌耐药株LoVo/Adr细胞多药耐药性的影响[J].2002,(7).
- [3]Ying HAN,Zhe-Yi Han,Xin-Min Zhou,etc.Expression and function of classical protein kinase C isoenzymes in gastric cancer cell line and its drug-resistant sublines[J].2002,(3).
- [4]韩英,时永全,李玲,等.蛋白激酶C同工酶PKC-α及PKC-βⅠ在胃癌及其耐药细胞中的表达和功能[J].2001,(2).
- [5]Xiao L,Ding L,Wang H,etc.Protein kinase C-epsilon promotes survival of lung cancer cells by suppressing apoptosis through dysregulation of the mitochondrial caspase pathway.[J].2002,277(38).
- [6]K, Jarzabek,P, Laudański,J, Dziecio?,etc.Protein kinase C involvement in proliferation and survival of breast cancer cells.[J].2002,40.
- [7]Philip Cornford,Jim Evans,Andrew Dodson,etc.Protein Kinase C Isoenzyme Patterns Characteristically Modulated in Early Prostate Cancer[J].1999,154(1).
- [8]Denise Way,Steven Smith,Sharmila Sivendran,etc.A protein kinase C inhibitor induces phenotypic reversion of ras-transformed pancreatic cancer cells and cooperatively blocks tumor cell proliferation with an anti-ras peptide[J].2002,49(6).
- [9]Kolhagen H,Schondorf T,Becker M,etc.Heterogeneity of proteinkinase C activity and PKC-zeta expression in clinical breast carcinomas.[J].2001,1(1).
- [10]Sagawa N,Fujita H,Banno Y,etc.Gelsolin suppresses tumorigenicity through inhibiting PKC activation in a human lung cancer cell line, PC10[J].2003.
- [11]Alvarez AM,Nakayama KI,Garcia Fernandez LF,etc.Aplidin induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C delta.[J].2002,21(49).
- [12]G H, Zhu,B C, Wong,E D, Slosberg,etc.Overexpression of protein kinase C-beta1 isoenzyme suppresses indomethacin-induced apoptosis in gastric epithelial cells.[J].2000,118.
- [13]Buchner K.The role of protein kinase C in the regulation of cell growth and in signalling to the cell nucleus.[J].2000,126(1).
- [14]C A, Carter.Protein kinase C as a drug target: implications for drug or diet prevention and treatment of cancer.[J].2000,1(2).
- [15]Masso-Welch PA,Darcy KM,Winston JS,etc.Altered expression and localization of PKC eta in human breast tumors.[J].2001,68(3).
- [16]Menon K,Shih C,Galbreath E,etc.Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human HT-29 colon carcinoma and human CaKi1 renal cell carcinoma xenografts.[J].2001,21(5).
- [17]P G, Goekjian,M R, Jirousek.Protein kinase C inhibitors as novel anticancer drugs.[J].2001,10.
- [18]M, Izawa,K, Teramachi.Down-regulation of protein kinase C activity by sorbitol rapidly induces apoptosis in human gastric cancer cell lines.[J].2001,6(5).